Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Enterprise Value (2016 - 2025)

Rockwell Medical's Enterprise Value history spans 16 years, with the latest figure at -$25.0 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 15.72% year-over-year to -$25.0 million; the TTM value through Dec 2025 reached -$25.0 million, down 15.72%, while the annual FY2025 figure was -$25.0 million, 15.72% down from the prior year.
  • Enterprise Value reached -$25.0 million in Q4 2025 per RMTI's latest filing, down from -$23.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$8.6 million in Q1 2024 to a low of -$46.1 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$21.6 million, with a median of -$20.0 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: soared 78.51% in 2022, then crashed 101.08% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$22.4 million in 2021, then rose by 4.22% to -$21.5 million in 2022, then soared by 49.12% to -$10.9 million in 2023, then crashed by 97.55% to -$21.6 million in 2024, then fell by 15.72% to -$25.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Enterprise Value are -$25.0 million (Q4 2025), -$23.7 million (Q3 2025), and -$18.4 million (Q2 2025).